1As of 09/03/09. Number of bioassays in which the compound was tested/number in which the compound was active/number in which the compound has been confirmed as an inhibitor.
The Mdr1ab(−/−) mice (3 per dose rate) injected subcutaneously at dose rates of 0.11, 0.40 and 0.69 µmol/kg bw for IVM and 1.27, 1.64 and 2.56 µmol/kg bw for MOX were observed and the development of s